The technology will allow Carlsmed to deliver its aprevo personalized spinal fusion implants to hospitals in fewer than 10 days, according to a Nov. 6 news release from the company.
Reduced lead times will make the implants more readily available by shortening scheduling windows, the release said.
Carlsmed’s device portfolio is indicated for use in lumbar spine fusion surgery. The launch of aprevo for cervical fusions is expected by the end of 2025.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
